Mabion S.A. Cash Flow Conversion Efficiency

Latest as of June 2026: -0.268x

Mabion S.A. cash flow conversion efficiency. Based on the latest financial reports, Mabion S.A. (MAB) has a cash flow conversion efficiency ratio of -0.268x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (zł-6.47 Million ≈ $-1.78 Million USD) by net assets (zł24.15 Million ≈ $6.65 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Mabion S.A. (2009–2025)

Cash flow conversion efficiency of Mabion S.A. from 2009 to 2025. This chart illustrates how Mabion S.A.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View Mabion S.A. (MAB) share price today for real-time trading data and today's change.

Mabion S.A. Cash Flow Conversion Ratio Explained

Mabion S.A. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Mabion S.A. Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Mabion S.A. ranked by their cash flow conversion efficiency. Also see Mabion S.A. stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Veranda Learning Solutions Limited NSE:VERANDA	-0.045x
Namuga Co. Ltd KQ:190510	0.079x
Optomed PLC HE:OPTOMED	-0.052x
Abico FS Co Ltd TWO:8071	0.045x
DKLS Industries Bhd KLSE:7528	0.017x
Co2 Capsol AS OL:CAPSL	-0.288x
ContextVision AB OL:CONTX	0.047x
Arribatec Solutions ASA OL:ARR	0.035x

Annual Cash Flow Conversion Efficiency for Mabion S.A. (2009–2025)

The table below shows the annual cash flow conversion efficiency of Mabion S.A. from 2009 to 2025. Review free cash flow generation of Mabion S.A. to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	zł55.35 Million ≈ $15.23 Million	zł-41.59 Million ≈ $-11.45 Million	-0.751x	-310.06%
2024-12-31	zł111.44 Million ≈ $30.67 Million	zł39.86 Million ≈ $10.97 Million	0.358x	+1905.77%
2023-12-31	zł117.78 Million ≈ $32.41 Million	zł-2.33 Million ≈ $-642.08K	-0.020x	-103.90%
2022-12-31	zł76.51 Million ≈ $21.06 Million	zł38.84 Million ≈ $10.69 Million	0.508x	+182.24%
2021-12-31	zł53.31 Million ≈ $14.67 Million	zł-32.91 Million ≈ $-9.06 Million	-0.617x	-235.56%
2020-12-31	zł-77.39 Million ≈ $-21.30 Million	zł-35.24 Million ≈ $-9.70 Million	0.455x	-70.89%
2019-12-31	zł-21.58 Million ≈ $-5.94 Million	zł-33.76 Million ≈ $-9.29 Million	1.564x	+269.28%
2018-12-31	zł42.14 Million ≈ $11.60 Million	zł-38.94 Million ≈ $-10.72 Million	-0.924x	-192.46%
2017-12-31	zł-54.16 Million ≈ $-14.91 Million	zł-54.13 Million ≈ $-14.90 Million	0.999x	+124.49%
2016-12-31	zł3.73 Million ≈ $1.03 Million	zł-15.22 Million ≈ $-4.19 Million	-4.082x	-1433.70%
2015-12-31	zł127.64 Million ≈ $35.13 Million	zł-33.97 Million ≈ $-9.35 Million	-0.266x	-988.98%
2014-12-31	zł997.84 Million ≈ $274.62 Million	zł-24.39 Million ≈ $-6.71 Million	-0.024x	+53.89%
2013-12-31	zł520.55 Million ≈ $143.26 Million	zł-27.59 Million ≈ $-7.59 Million	-0.053x	-615.46%
2012-12-31	zł1.82 Billion ≈ $502.09 Million	zł-13.51 Million ≈ $-3.72 Million	-0.007x	+98.71%
2011-12-31	zł20.37 Million ≈ $5.60 Million	zł-11.74 Million ≈ $-3.23 Million	-0.576x	-794.40%
2010-12-31	zł21.72 Million ≈ $5.98 Million	zł-1.40 Million ≈ $-385.19K	-0.064x	-101.62%
2009-12-31	zł-74.80K ≈ $-20.59K	zł-298.41K ≈ $-82.13K	3.990x	--

About Mabion S.A.

WAR:MAB Poland Biotechnology

Market Cap

$34.70 Million

zł126.07 Million PLN

Market Cap Rank

#23050 Global

#219 in Poland

Share Price

zł7.80

Change (1 day)

+1.17%

52-Week Range

zł6.82 - zł9.63

All Time High

zł134.60